Drawing for ATLAS ANTIBODIES

USPTO serial 79267307

ATLAS ANTIBODIES

Reviewed by CopyMark Law Group

Status 654
Filing date
Status date
Registration date
—
Examiner
TENG, SIMON
Law office
TMEG LAW OFFICE 105

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ATLAS ANTIBODIES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mari-Elise Paul

Mari-Elise Paul McBrayer PLLC500 West Jefferson Street, Suite 2400LOUISVILLE, KY 40202United States

Goods and services

ClassDescriptionStatusFirst use
001Antibody reagents for scientific purposes; monoclonal antibodies for industrial use; monoclonal antibodies for scientific use; tagged antibodies for scientific use; tagged antibodies for laboratory use; immunological antibodies, other than for medical use; monoclonal antibody reagents, other than for medical use; monoclonal antibodies for diagnostic use other than for medical purposes; proteins for binding antibodies other than for medical purposes; proteins for detecting antibodies other than for medical use; antibodies for scientific purposes, other than for medical or veterinary use; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; monoclonal antibodies for the quantitative determination of leucocyte subsets other than for medical use; reagents for use in the development of monoclonal antibodies other than for medical or veterinary purposes; reagents for use in the development of hybridoma antibodies other than for medical or veterinary purposes; monoclonal antibodies for use in the study of haematopoietic systems other than medical use; monoclonal antibodies for the qualitative determination of leucocyte subsets other than for medical useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 21, 2026RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Sep 9, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Sep 5, 2025RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Mar 4, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Feb 28, 2025ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Sep 3, 2024RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Apr 10, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 10, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Apr 10, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 10, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 4, 2024RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Feb 20, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Feb 20, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 20, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Feb 20, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 20, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 5, 2023RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Mar 7, 2023RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Sep 7, 2022RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Mar 7, 2022RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Sep 7, 2021RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Mar 7, 2021OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 4, 2021RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Feb 17, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 17, 2021OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Sep 4, 2020RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Mar 3, 2020GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Mar 3, 2020GNSLLETTER OF SUSPENSION E-MAILED—
Mar 3, 2020CNSLSUSPENSION LETTER WRITTEN—
Feb 25, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 25, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 21, 2020ALIEASSIGNED TO LIE—
Feb 17, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 17, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 17, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 17, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 29, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 29, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 26, 2019RFNTREFUSAL PROCESSED BY IB—
Oct 4, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 4, 2019RFRRREFUSAL PROCESSED BY MPU—
Sep 21, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 20, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 19, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 17, 2019DOCKASSIGNED TO EXAMINER—
Sep 17, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 12, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance